跳至主要内容
临床试验/NCT03668522
NCT03668522Unknown不适用

Clinical Research of the Molecular Phenotype Distribution of H3F3AK27M in Spinal Glioma and Its Impact on TMZ Chemoradiotherapy

Southern Medical University, China1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2018年9月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
60
试验地点
1
主要终点
positive

研究概览

简要总结

H3F3AK27M may be a feature of primary spinal cord glioma and affect the outcome and prognosis of TMZ chemoradiotherapy.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

性别
All
接受健康志愿者

入选标准

  • Surgical treatment and pathological confirmation of spinal glioma in our department and is the first case without any treatment before operation.

排除标准

  • The tumor is recurrent or has been treated before operation.

结局指标

主要结局

positive

时间窗: through study completion, an average of 1 year

positive of H3F3AK27M

次要结局

未报告次要终点

研究者

发起方
Southern Medical University, China
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yuntao Lu

adjunct professor

Southern Medical University, China

研究点 (1)

Loading locations...

相似试验